These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34756279)

  • 1. «Do Not Do» recommendations for retinopathies: A mixed consensus study.
    Pablo L; Beckford CA; Martin-Delgado J; Ferro Osuna M; Fernández-Ferreiro A; Fernández Rodriguez MI; Rodriguez Cid MJ; Méndez S; Torres A; Ignacio E; Mira JJ
    Arch Soc Esp Oftalmol (Engl Ed); 2021 Nov; 96(11):578-586. PubMed ID: 34756279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. «Do Not Do» recommendations for retinopathies: A mixed consensus study.
    Pablo L; Beckford CA; Martin-Delgado J; Ferro Osuna M; Fernández-Ferreiro A; Fernández Rodriguez MI; Rodríguez Cid MJ; Méndez S; Torres A; Ignacio E; Mira JJ
    Arch Soc Esp Oftalmol (Engl Ed); 2021 Feb; ():. PubMed ID: 33612365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of costs associated with the management and morbidity of diabetic macular oedema and macular oedema secondary to retinal vein occlusion.
    Abraldes MJ; Pareja A; Roura M;
    Arch Soc Esp Oftalmol; 2016 Jun; 91(6):273-80. PubMed ID: 26810908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of aflibercept in routine clinical practice].
    Cabrera López F
    Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():29-34. PubMed ID: 25925049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion.
    Astam N; Batioğlu F; Ozmert E
    Int Ophthalmol; 2009 Oct; 29(5):343-8. PubMed ID: 18553061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of VEGF in diseases of the retina].
    Barquet LA
    Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():3-5. PubMed ID: 25925044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiopathy and the eye].
    Rencová E
    Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis.
    Jackson TL; Nicod E; Angelis A; Grimaccia F; Prevost AT; Simpson AR; Kanavos P
    Retina; 2013 Jun; 33(6):1099-108. PubMed ID: 23591535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral diabetic macular oedema secondary to central retinal vein congestion.
    Christoffersen N; Larsen M
    Acta Ophthalmol Scand; 2004 Oct; 82(5):591-5. PubMed ID: 15453859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser.
    Friberg TR; Karatza EC
    Ophthalmology; 1997 Dec; 104(12):2030-8. PubMed ID: 9400762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aqueous levels of VEGF correlate with retinal non-perfusion areas in patients with diabetic macular edema and macular edema secondary to central retinal vein occlusion.
    Machalinska A; Mozolewska-Piotrowska K; Czepita M; Spoz W; Dzieciolowska M; Kubasik-Kladna K; Szmatloch K; Lubinski W; Safranow K; Pius-Sadowska E
    Klin Oczna; 2016 Sep; 117(4):225-229. PubMed ID: 29727107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
    Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG
    Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RETINAL VEIN OCCLUSION IN A PATIENT WITH MATERNALLY INHERITED DIABETES AND DEAFNESS.
    Sanfilippo CJ; Prasad P; Sarraf D
    Retin Cases Brief Rep; 2017 Winter; 11 Suppl 1():S41-S43. PubMed ID: 27548038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema.
    García-Arumí J; Fonollosa A; Macià C; Hernandez C; Martinez-Castillo V; Boixadera A; Zapata MA; Simo R
    Eye (Lond); 2009 May; 23(5):1066-71. PubMed ID: 18670462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What can anti-VEGF therapy achieve in clinical routine? : Effectiveness of anti-VEGF therapy in patients with macular diseases in clinical routine on 1492 eyes in Austria].
    Wiesinger K; Reinelt P; Ennemoser A; Edelmayr M; Schönherr U
    Ophthalmologe; 2017 Jul; 114(7):639-645. PubMed ID: 27815675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis.
    Pham B; Thomas SM; Lillie E; Lee T; Hamid J; Richter T; Janoudi G; Agarwal A; Sharpe JP; Scott A; Warren R; Brahmbhatt R; Macdonald E; Straus SE; Tricco AC
    BMJ Open; 2019 May; 9(5):e022031. PubMed ID: 31142516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A cost-effectiveness study of dexamethasone implants in macular edema].
    Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
    Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Design of the ORCA module in the OCEAN study : Evaluation of SD-OCT results in daily routine practice].
    Heimes B; Schick T; Brinkmann CK; Wiedon A; Haegele B; Kirchhof B; Holz FG; Pauleikhoff D; Ziemssen F; Liakopoulos S; Spital G; Schmitz-Valckenberg S
    Ophthalmologe; 2016 Jul; 113(7):570-80. PubMed ID: 26868827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.
    Cehofski LJ; Honoré B; Vorum H
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2009; 29(10):1396-403. PubMed ID: 19898177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.